Description
Assessment of sensitivity for coagulation factor deficiency in routine coagulation tests
- You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart
Article: Assessment of sensitivity for coagulation factor deficiency in routine coagulation tests
€3.03
Reviews
There are no reviews yet.